• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

After Kaletra setback, AbbVie joins forces with biotech, academia for experimental COVID-19...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 05, 2020 at 10:52: AM
via Earlier this year, AbbVie tried and stumbled in a clinical trial using its HIV med Kaletra to help certain COVID-19 patients; now, it’s tapping a triumvirate of life science groups to develop a new antibody for the virus.

article source
 




Top Bottom
Back
Quote